bluebird bio (NASDAQ: BLUE) released earnings last week. Without any meaningful revenue, or much to fill in about the company’s pipeline, it was a sleepy first-quarter update for the Cambridge, Mass.-based biotech.
Metric
bluebird bio (NASDAQ: BLUE) released earnings last week. Without any meaningful revenue, or much to fill in about the company’s pipeline, it was a sleepy first-quarter update for the Cambridge, Mass.-based biotech.
Metric